Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies.

Authors :: Bogenberger JM
Delman D
Hansen N
Valdez R
Fauble V
Mesa RA
Tibes R
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2015 Jan; Vol. 56 (1), pp. 226-9. Date of Electronic Publication: 2014 Jun 17.
Publication Year :: 2015

Subjects :: Cell Line, Tumor
Humans
Leukemia, Myeloid metabolism
Piperazines pharmacology
Proto-Oncogene Proteins c-bcl-2 antagonists & inhibitors
Proto-Oncogene Proteins c-bcl-2 metabolism
Antineoplastic Agents pharmacology
Azacitidine pharmacology
Biphenyl Compounds pharmacology
Bridged Bicyclo Compounds, Heterocyclic pharmacology
Nitrophenols pharmacology
Sulfonamides pharmacology

Full Text Access

Tools